Casss

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 770048350 ✦ Sacramento, CA ✦ Designated as a 501(c)(6)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Casss?

Casss, based in Sacramento, California, is a nonprofit organization dedicated to fostering collaboration and knowledge sharing among industry professionals, regulatory agents, academic researchers, and students. Their primary focus is on biopharmaceutical development and regulation, hosting conferences and meetings to discuss and disseminate technical data. By bringing together experts from various fields, Casss aims to tackle scientific and technical challenges and advance the field. The organization also provides educational, employment, and networking opportunities for its members. With a team of 13 individuals, Casss hosts international symposia for scientists in the biotechnology, pharmaceutical, and academic spheres.


Official website here: www.casss.org

Is Casss legitimate?

Casss is a legitimate nonprofit organization registered as a 501(c)(6) entity. Casss submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $206,572
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,183,000

For more financial information, click here


Official website here: www.casss.org

What is the mission statement of Casss?

Casss, an organization that bridges the gap between industry, academia, and regulatory agencies, is committed to solving scientific and technical challenges in the field of biopharmaceutical development. Their mission is twofold. Firstly, they sponsor international symposia for scientists in the biotechnology, pharmaceutical, and academic sectors, providing a platform for the exchange of valuable technical data related to biopharmaceutical development and regulation. Secondly, Casss offers educational, employment, and networking opportunities for its members, fostering a supportive community within the field. By organizing scientific conferences and meetings, they facilitate discussions and dissemination of information among industry professionals, regulatory agents, academic researchers, and students.


Official website here: www.casss.org

Who is the CEO of Casss?

David J Bergeson is the Past Pres (End 12/31/21) of Casss. The CEO's salary of Casss is $195,636 and their total compensation is $206,572.


Official website here: www.casss.org

What is the revenue of Casss?

Casss's revenue in 2022 was $3,174,552.


Official website here: www.casss.org

Who are the executives of Casss and what are their salaries?

The average compensation at Casss during 2022 was $106,890. There are 13 employees and 313 volunteers at Casss.


Here are 19 key members and their salaries (Casss's CEO's salary is $195,636 and their total compensation is $206,572):


Nadine Ritter (Past Pres (End 12/31/21))
  • Compensation: $0
  • Related: $0
  • Other: $0
Julia Edwards (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Steven Cohen (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Andrew Chang (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Carmilia Jimenez Ramirez (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sarah Kennett (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Joseph Kutza (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kathy Lee (Vice Pres 1/1/22)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jamie Moore (Director As Of 1/1/2022)
  • Compensation: $0
  • Related: $0
  • Other: $0
Brian Nunnally (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mark Schenerman (Director Term End 12/31/21)
  • Compensation: $0
  • Related: $0
  • Other: $0
Cari Sanger-Van De Griend (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Patrick Swann (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Hansjoerg Toll (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Stephanie Flores (Executive Director And Ceo)
  • Compensation: $195,636
  • Related: $0
  • Other: $10,936
Karen Bertani (Dir Of Global Engagement/Knowledge Sharin)
  • Compensation: $161,907
  • Related: $0
  • Other: $26,687
Renee Olson (Senior Program Manager/Marketing)
  • Compensation: $118,413
  • Related: $0
  • Other: $14,287
Anne Ornelas (Senior Operations Manager)
  • Compensation: $121,282
  • Related: $0
  • Other: $19,469
Catherine Stewart (Dir Of Finance And Hr Admin)
  • Compensation: $146,105
  • Related: $0
  • Other: $22,011


Official website here: www.casss.org

Where can I find the form 990 for Casss?

Casss's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.casss.org

Learn more at the official website: www.casss.org

Mission Statement of Casss

Casss, a collective of professionals from various sectors, including industry, academia, and regulatory agencies, is dedicated to addressing scientific and technical challenges in the field of biopharmaceutical development. Their mission is twofold: firstly, they sponsor international symposia for scientists in the biotechnology, pharmaceutical, and academic arenas. These events provide a platform for the exchange of valuable technical data related to biopharmaceutical development and regulation. Secondly, Casss offers educational, employment, and networking opportunities for its members, thereby fostering growth and collaboration within the community. Their conferences and meetings, meticulously designed and coordinated, bring together industry and regulatory professionals, academic researchers, and students, encouraging open discussions and dissemination of knowledge in the field.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Cass's impact lies in its ability to foster collaboration among diverse professionals in the biopharmaceutical field, including industry experts, academic researchers, and regulatory bodies. By organizing scientific conferences and meetings, Cass creates a platform for the exchange of critical knowledge and technical data that drives innovation in biopharmaceutical development. These gatherings not only facilitate discussions on pressing issues but also encourage the dissemination of valuable insights that can influence regulatory practices and scientific research.

Furthermore, Cass's commitment to sponsoring international symposia provides a unique opportunity for scientists across various sectors to come together, share their findings, and address challenges in biotechnology and pharmaceuticals. This collaborative environment is essential for advancing the field, as it helps bridge gaps between theory and practice, ensuring that scientific advancements are effectively translated into regulatory compliance and practical applications.

In addition to these initiatives, Cass enhances career development through educational opportunities and networking events, allowing members to connect, share experiences, and explore employment possibilities. This focus on professional growth supports the ongoing advancement of the biopharmaceutical sector, ultimately contributing to more effective therapies and improved health outcomes.




This information is meant to be a general summary of Casss. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$3,174,552 (2022)
Expenses
$3,672,026 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $163,035
  • Program Service Revenue: $3,011,517
  • Gross Receipts: $3,698,141

Assets and Liabilities:

  • Total Assets: $4,508,565
  • Total Liabilities: $1,202,430
  • Net Assets: $3,306,135

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

SYMPOSIUM/CONFERENCES

Revenue

$3,011,517

Organization Details

Founding Year

1983

Principal Officer

David J Bergeson

Main Address

1111 EXPOSITION BLVD BUILDING 100, SACRAMENTO, CA, 95815

NTEE Category

Code: V00 - Social research

If you are a representative of Casss and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.